VAC4EU active safety surveillance study of the BNT162B2 COVID-19 vaccine in five European countries: Study design and first results

Weibel, D.; Sturkenboom, M.; Eijkemans, R.; van den Bor, R.; Elbers, R.; Plana, E.; de Albeniz, X. G.; Weinrib, R.; Yefimenko, N.; Poblador-Plou, B.; Bianchini, E.; Stona, L.; Swart, K.; Bartolini, C. C.; Hyeraci, G.; Roy, D.; Lupattelli, A.; Villalobos, F.; Barbieri, E.; Garg, R.; Rubino, H.; De Luise, C.; Arana, A.

Weibel, D.; Sturkenboom, M.; Eijkemans, R.; van den Bor, R.; Elbers, R.; Plana, E.; de Albeniz, X. G.; Weinrib, R.; Yefimenko, N.; Poblador-Plou, B.; Bianchini, E.; Stona, L.; Swart, K.; Bartolini, C. C.; Hyeraci, G.; Roy, D.; Lupattelli, A.; Villalobos, F.; Barbieri, E.; Garg, R.; Rubino, H.; De Luise, C.; Arana, A..

Pharmacoepidemiology and Drug Safety ; 31:627-628, 2022.

Article in English | Web of Science | ID: covidwho-2084280

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Topics: Vaccines Language: English Journal: Pharmacoepidemiology and Drug Safety Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML